Lourd Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $451K | Buy |
6,200
+325
| +6% | +$23.6K | 0.04% | 65 |
|
2019
Q1 | $473K | Sell |
5,875
-3,669
| -38% | -$295K | 0.05% | 61 |
|
2018
Q4 | $880K | Buy |
9,544
+54
| +0.6% | +$4.98K | 0.07% | 67 |
|
2018
Q3 | $898K | Buy |
+9,490
| New | +$898K | 0.06% | 73 |
|
2018
Q1 | – | Sell |
-9,596
| Closed | -$928K | – | 121 |
|
2017
Q4 | $928K | Buy |
9,596
+3,328
| +53% | +$322K | 0.06% | 77 |
|
2017
Q3 | $557K | Buy |
6,268
+13
| +0.2% | +$1.16K | 0.05% | 58 |
|
2017
Q2 | $454K | Sell |
6,255
-94
| -1% | -$6.82K | 0.04% | 64 |
|
2017
Q1 | $414K | Buy |
6,349
+154
| +2% | +$10K | 0.04% | 66 |
|
2016
Q4 | $388K | Sell |
6,195
-101
| -2% | -$6.33K | 0.04% | 60 |
|
2016
Q3 | $397K | Sell |
6,296
-79
| -1% | -$4.98K | 0.04% | 59 |
|
2016
Q2 | $395K | Buy |
6,375
+229
| +4% | +$14.2K | 0.11% | 68 |
|
2016
Q1 | $351K | Buy |
6,146
+334
| +6% | +$19.1K | 0.04% | 78 |
|
2015
Q4 | $344K | Buy |
5,812
+725
| +14% | +$42.9K | 0.04% | 78 |
|
2015
Q3 | $277K | Sell |
5,087
-5
| -0.1% | -$272 | 0.03% | 86 |
|
2015
Q2 | $342K | Buy |
5,092
+120
| +2% | +$8.06K | 0.04% | 83 |
|
2015
Q1 | $291K | Buy |
4,972
+96
| +2% | +$5.62K | 0.03% | 100 |
|
2014
Q4 | $319K | Sell |
4,876
-2,333
| -32% | -$153K | 0.03% | 86 |
|
2014
Q3 | $416K | Sell |
7,209
-1,488
| -17% | -$85.9K | 0.04% | 65 |
|
2014
Q2 | $491K | Buy |
8,697
+1,797
| +26% | +$101K | 0.05% | 62 |
|
2014
Q1 | $355K | Sell |
6,900
-600
| -8% | -$30.9K | 0.04% | 68 |
|
2013
Q4 | $396K | Hold |
7,500
| – | – | 0.04% | 64 |
|
2013
Q3 | $335K | Hold |
7,500
| – | – | 0.04% | 70 |
|
2013
Q2 | $310K | Buy |
+7,500
| New | +$310K | 0.04% | 77 |
|